[UTHR]

Mid 2026-08-31 07:01:37

United Therapeutics highlights new data supporting two FDA filings

Row 2026-08-15 13:53:05

United Therapeutics CEO Martine Rothblatt sells $4.79m in stock

Row 2026-08-14 12:31:29

United Therapeutics CEO Rothblatt sells $4.89m in stock

Mid 2026-08-06 01:33:37

United Therapeutics anticipates potential 2027 approvals for ralinepag and Tyvaso IPF while holding 2026 revenue outlook unchanged

Row 2026-08-05 19:38:15

United Therapeutics GAAP EPS of $7.27 beats by $0.41, revenue of $783.3M misses by $21.35M